• Home
  • Contact Us!
  • Privacy Policy

Radio Metta

  • Home
  • Business
  • Education
  • Health
  • Home Deco
  • News
  • Real Estate
  • Technology
  • Contact Us!
  • Privacy Policy
Home» Health»Memory drug enters clinical trial, may help treat cognitive disorders

Memory drug enters clinical trial, may help treat cognitive disorders

Saheli 07 Apr 2016 Health Comments Off on Memory drug enters clinical trial, may help treat cognitive disorders 726 Views

A memory drug developed by the National Institutes of Health and Tetra Discovery Partners that may help treat or prevent cognitive disorders has been moved into a small clinical trial, the agency announced in a press release.

The drug, BPN14770, is aimed at improving a biochemical pathway responsible for memory and nerve synapse formation in the brain, unlike many drugs targeting the buildup of amyloid plaques that contribute to the development of Alzheimer’s disease and other cognitive disorders.

BPN14770 is the first drug to make it out of the NIH’s Blueprint Neurotherapeutics Network, which pairs scientists developing molecules with medical application with companies that have experience developing them into usable, marketable drugs.

“There is a great need for additional new drug targets and treatment approaches for Alzheimer’s disease that effectively reduce symptoms, and potentially also slow disease progression,” Dr. Scott Reines, chief medical officer of Tetra, said in a press release. “Most current Alzheimer’s disease drug development is focused on amyloid targeted approaches, which even if successful are likely to be more effective when used in combination with drugs addressing other mechanisms of the disease. The PDE4 biochemical pathway of memory and nerve synapse formation targeted by BPN14770 is well documented.”

Researchers will recruit 48 healthy volunteers to test the safety, tolerability, and pharmacokinetics of the drug in the body. Based on the results of the Phase 1 trial, the researchers will mount a multiple ascending dose study with young and elderly participants to begin assessing the short- and long-term effects of the drug.

“Researchers have shown great interest in exploring how boosting synapse formation can potentially benefit not only Alzheimer’s disease but also other cognitive disorders such as schizophrenia and learning/developmental disabilities, such as Fragile X syndrome,” Reines said. “We greatly look forward to advancing our clinical studies of BPN14770 to understand its potential in treating these serious neurological conditions, which represent enormous unmet medical needs.”

[Source:- UPI]

clinical cognitive disorders Drug enters help may memory treat trial 2016-04-07
Tags clinical cognitive disorders Drug enters help may memory treat trial
Facebook Twitter Stumble linkedin Pinterest More

Authors

Posted by : Saheli
Previous Article :

Metro trains with no drivers soon

Next Article :

Not willing to take anymore chances, govt. keeps paper-setters incommunicado

Related Articles

Healthy.io and Geisinger Present Milestone Data at AHA 2024: Advancing Digital Healthcare and Kidney Disease Detection

Healthy.io and Geisinger Present Milestone Data at AHA 2024: Advancing Digital Healthcare and Kidney Disease Detection

admin 16 Nov 2026
The Best Healthy Living Blogs of 2020

The Best Healthy Living Blogs of 2020

admin 05 Nov 2026
Can Men Hold Off on Treating Recurring Prostate Cancer?

Can Men Hold Off on Treating Recurring Prostate Cancer?

admin 04 Nov 2026

Latest Post

Technology Companies Step Up Hiring for AI Agent Development and Deployment
Technology

Technology Companies Step Up Hiring for AI Agent Development and Deployment

admin 20 Nov 2026
Beyond Your Apartment: Why a Strong Community Is Your Best Real Estate Investment
Real Estate

Beyond Your Apartment: Why a Strong Community Is Your Best Real Estate Investment

admin 19 Nov 2026
Downton Abbey Costumes Exhibition in Boston and Now on Auction in 2025
Home Deco

Downton Abbey Costumes Exhibition in Boston and Now on Auction in 2025

admin 16 Nov 2026
Healthy.io and Geisinger Present Milestone Data at AHA 2024: Advancing Digital Healthcare and Kidney Disease Detection
Health

Healthy.io and Geisinger Present Milestone Data at AHA 2024: Advancing Digital Healthcare and Kidney Disease Detection

admin 16 Nov 2026
The Best Healthy Living Blogs of 2020
Health

The Best Healthy Living Blogs of 2020

admin 05 Nov 2026
Can Men Hold Off on Treating Recurring Prostate Cancer?
Health

Can Men Hold Off on Treating Recurring Prostate Cancer?

admin 04 Nov 2026
Migraine or Just a Bad Headache? How to Tell the Difference
Health

Migraine or Just a Bad Headache? How to Tell the Difference

admin 31 Oct 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    
  • Home
  • Contact Us!
  • Privacy Policy
Copyright 2016, All Rights Reserved
Magazine Blog News WordPress Theme